← Back to Search

Supportive Care App for Lung Cancer

N/A
Waitlist Available
Led By Joseph Greer, PHD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >18 years
Diagnosed with unresectable Stage III or IV NSCLC in the past twelve weeks and receiving care with palliative intent (per clinician documentation in the electronic health record)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial is testing whether a mobile app can help improve symptoms, coping skills, and quality of life for patients with non-small cell lung cancer.

Who is the study for?
This trial is for adults over 18 with advanced non-small cell lung cancer (NSCLC) who plan to receive care at participating sites and can interact in English. They should be recently diagnosed, not planning surgery, and receiving palliative care. Those with significant psychiatric disorders or cognitive impairments that could hinder participation are excluded.Check my eligibility
What is being tested?
The study is examining the effectiveness of a supportive care mobile app designed to improve symptoms, coping skills, and quality of life for patients with NSCLC compared to usual care without the app.See study design
What are the potential side effects?
Since this trial involves a mobile application for supportive care rather than medication, there are no direct medical side effects. However, users may experience stress or emotional discomfort when engaging with their illness through the app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I was diagnosed with advanced lung cancer that can't be removed by surgery within the last 12 weeks.
Select...
I can care for myself but may not be able to do heavy physical work.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Study feasibility based on rates of participant recruitment and completion of assigned study procedures
Secondary outcome measures
Compare patient-reported coping between study groups on the Brief COPE Scale
Compare patient-reported psychological distress between study groups on the Hospital Anxiety and Depression Scale
Compare patient-reported quality of life between study groups on the Functional Assessment of Cancer Therapy-Lung Scale
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Supportive Care Mobile ApplicationExperimental Treatment2 Interventions
Complete study questionnaires at two time points: upon enrollment at baseline prior to randomization approximately 12 weeks after the baseline assessment time point. Participants will be provided with a study-issued tablet computer to access mobile app and receive a comprehensive tutorial and detailed instructions on how to use the app. Participants will have approximately 10 weeks to complete the intervention modules at self initiated pace. The app will provide prompts as reminders to complete the modules. Participants will receive standard oncology care. Study staff will monitor participant use of supportive care services, such as social work, psychology, psychiatry, and palliative care.
Group II: Usual CareActive Control1 Intervention
Complete study questionnaires at two time points: upon enrollment at baseline prior to randomization approximately 12 weeks after the baseline assessment time point. Participants will receive standard oncology care. Study staff will monitor participant use of supportive care services, such as social work, psychology, psychiatry, and palliative care.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,198,185 Total Patients Enrolled
National Comprehensive Cancer NetworkNETWORK
115 Previous Clinical Trials
7,515 Total Patients Enrolled
Joseph Greer, PHDPrincipal InvestigatorMassachusetts General Hospital

Media Library

Supportive Care Mobile Application Clinical Trial Eligibility Overview. Trial Name: NCT04629300 — N/A
Non-Small Cell Lung Cancer Research Study Groups: Supportive Care Mobile Application, Usual Care
Non-Small Cell Lung Cancer Clinical Trial 2023: Supportive Care Mobile Application Highlights & Side Effects. Trial Name: NCT04629300 — N/A
Supportive Care Mobile Application 2023 Treatment Timeline for Medical Study. Trial Name: NCT04629300 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current size of the sample population involved in this trial?

"Affirmative, the information located on clinicaltrials.gov confirms that this research project is currently accepting participants. This trial was first published on October 15th 2021 and subsequently revised on November 2nd 2021. In total, 120 subjects are needed at three separate healthcare facilities."

Answered by AI

Is there still an opportunity to join this clinical investigation?

"Affirmative. Clinicaltrials.gov documents show that recruitment for this medical trial, which was originally posted on October 15th 2021, is ongoing. Approximately 120 subjects are needed to be recruited from 3 different clinical centres."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
What site did they apply to?
Dana-Farber Cancer Institute
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Supportive Care Mobile Application for Patients With NSCLC
Joseph A. Greer, Ph.D. 2021. "Supportive Care Mobile Application for Patients With NSCLC". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04629300.
~34 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top